The Biden-Harris Administration recently announced various actions to lower healthcare and prescription drug costs. In one action, the National Institute of Standards and Technology (NIST) released in December 2023 a draft...more
2/2/2024
/ Bayh-Dole Act ,
Biden Administration ,
Comment Period ,
Disclosure Requirements ,
Drug Pricing ,
Federal Funding ,
Healthcare ,
Healthcare Reform ,
Innovation Patent ,
Inventions ,
Licensees ,
March-in-Rights ,
NIST ,
Patent Applications ,
Patent Ownership ,
Patents ,
Pharmaceutical Industry ,
Prescription Drugs ,
Public Comment
Organizations that receive federal funds or that license technology from third parties that receive Federal funds need to be aware of Federal funding obligations under the Bayh-Dole Act. Any invention conceived or reduced to...more
7/29/2020
/ Bayh-Dole Act ,
Compliance ,
Disclosure Requirements ,
Employment Contract ,
Federal Contractors ,
Federal Funding ,
Inventions ,
IP License ,
National Institute of Health (NIH) ,
Patent Applications ,
Patent Ownership ,
Patent Prosecution ,
Reporting Requirements ,
Retaining Party
Businesses and nonprofits that receive funding under a federal government agreement (e.g., contract, cooperative agreement, or grant) executed after May 14, 2018, are subject to the updated regulatory provisions that...more